9067-32-7 Sodium hyaluronate CAS NO.9067-32-7

Sodium hyaluronate, CAS No： 9067-32-7 Hyaluronate acid  Cosmetic  moisturizer 

Sodium hyaluronate

INCI Name: Sodium hyaluronate

CAS No.: 9067-32-7

EINECS No.: 618-620-0

Molecular Formula: C14H22NNaO11

Molecular Weight: 403.31

Property: Sodium Hyaluronate(Hyaluronic acid) is a type of polysaccharide, Also known as hyaluronate, it occurs

naturally in the human body and is central to regulating cell growth and renewal. In fact, it is found extensively in

connective, epithelial, and neural cells. As such, hyaluronic acid has found its way into many skin care products, it can

retain moisture, keep the skin firm, and prevent wrinkles by adding volume to the skin..It is also used to prevent the effects

of aging.

Specification:

Appearance： White powder

Glycuronic Acid ≥44%

Sodium Hyaluronate ≥91%

Molecular Weight ：Measured Value

Limiting Viscosity ：Measured Value

Proteins <0.1%

PH (0.5% Water Solution) 5.0-8.5

Transparency(0.5% Water Solution) ≥99%

Loss on Drying ≤10.0%

Residue on Ignition ≤20.0%

Heavy Metals ≤10ppm

Lead(Pb) ≤3ppm

Application:

Food grade: Oral hyaluronic acid can make the skin moist, smooth, soft and elastic; it can delay aging and prevent the occurrence of arthritis, arteriosclerosis, pulse disturbance and brain atrophy.

Cosmetic grade:

Skin care products: cream; lotion; lotion; essence: gel: facial mask, etc.

Cleaning products: facial cleanser: shower gel, etc.

Hair supplies: shampoo; conditioner; hair restorer: hair spray

Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.

We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.

In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.

In 2008, We passed ISO quality system certificate

In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.

In 2016,  obtain a registered trademark “ BJM ”.

In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.

In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.

In 2020, we registered BJM Pharm Yunmeng Co., Ltd,  and the new production base settled in Geputan chemical park with  a total area of 50000 square meters.

We are specialized in the R&D ,production and sales of Erdosteine ,Pirfenidone, Telmisartan, Letrozole , Sitagliptin phosphate, Dapagliflozin , Tris , IPTG and related intermediates.

We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends.